Bioprinting Laboratories, Inc.

Bioprinting Laboratories Inc. is an innovative startup company advancing high-throughput, human-relevant in vitro testing. We have designed and commercialized a suite of pillar and perfusion plate products that support organoids, tumor spheroids, and immune-tumor cell co-cultures for predictive toxicity, efficacy, and immuno-oncology applications. Our product lineup includes the 36PillarPlate™, 36PerfusionPlate™, 144PillarPlate™, 144PerfusionPlate™, 384PillarPlate™, 384DeepwellPlate™, 36PetriLid™, 144PetriLid™ and LoadingPlate™—each optimized for automation, scalability, and reproducibility of 3D cell culture. By integrating organoid biology with engineering precision, our platform enables pharma, biotech, and academic researchers to accelerate drug discovery, reduce animal testing, and generate physiologically relevant data at scale.